Retour sur lavenir.net
   CMB.TECH 12.400 € (0,00 %)     COLRUYT 36.100 € (+0,39 %)     MONTEA 66.300 € (-0,90 %)     BIOTALYS 3.150 € (+1,78 %)     ACKERMANS V.HAAREN 283.800 € (-0,70 %)     AEDIFICA 70.500 € (-0,14 %)     AB INBEV 71.720 € (-1,29 %)     WDP 21.940 € (-0,54 %)     TESSENDERLO 20.100 € (+3,93 %)     ARGENX SE 816.600 € (+0,64 %)     AZELIS GROUP 9.150 € (-1,67 %)     BPOST 1.542 € (-0,52 %)     GBL 79.500 € (-0,25 %)     D'IETEREN GROUP 173.800 € (+2,00 %)     DEME GROUP 173.800 € (-0,69 %)     SYENSQO 63.650 € (-1,47 %)     FAGRON 24.200 € (+0,41 %)     VGP 84.700 € (+0,59 %)     KBC 119.800 € (+0,42 %)     ATENOR 1.680 € (+1,82 %)     NYXOAH 1.588 € (+5,03 %)     KINEPOLIS GROUP 34.650 € (-2,26 %)     UCB 264.300 € (+0,88 %)     SOLVAY 26.200 € (-0,30 %)     AGEAS 69.850 € (-0,21 %)     KBC ANCORA 83.000 € (+1,10 %)     PROXIMUS 5.775 € (-1,28 %)     RECTICEL 10.920 € (-0,36 %)     IMMOBEL 23.400 € (0,00 %)     OPTION 5.440 € (-0,37 %)     IBA 17.160 € (+1,54 %)     ELIA GROUP 138.300 € (-1,07 %)     UMICORE 20.200 € (-0,20 %)     TINC 11.360 € (-0,70 %)     ONTEX GROUP 2.410 € (-0,41 %)     TUBIZE-FIN 229.600 € (-0,61 %)     MELEXIS 79.250 € (+1,47 %)     EVS 27.400 € (+0,18 %)     GIMV 45.250 € (-2,27 %)     SOFINA 223.600 € (+0,45 %)     BEKAERT 39.300 € (+0,64 %)     ONWARD MEDICAL 2.515 € (0,00 %)     SHURGARD 25.800 € (+0,78 %)     BREDERODE 105.000 € (+0,38 %)     CIE BOIS SAUVAGE 306.000 € (-0,33 %)     VASTNED 29.500 € (-0,17 %)     TITAN S.A. 50.650 € (-2,31 %)     HOME INVEST BE. 19.280 € (+0,73 %)     LOTUS BAKERIES 11 560.000 € (-0,52 %)     SIPEF 91.700 € (-0,43 %)     CENERGY 22.840 € (-0,87 %)     XIOR 26.500 € (+0,76 %)     NYRSTAR 0.059 € (-6,94 %)     JENSEN-GROUP 85.000 € (+0,24 %)     FLORIDIENNE 60.000 € (0,00 %)     MOURY CONSTRUCT 754.000 € (0,00 %)     WHITESTONE GROUP 17.100 € (+0,59 %)     IMMO MCC 525.000 € (+0,96 %)     CO.BR.HA 1 840.000 € (+0,55 %)     PAYTON PLANAR 8.250 € (0,00 %)  
   EXOSENS 59.100 € (+3,50 %)     EMEIS 14.310 € (+1,85 %)     NICOX 0.374 € (-1,06 %)     PLANISWARE 19.180 € (+5,50 %)     PULLUP ENTERTAIN 8.140 € (+1,88 %)     VIRIDIEN 79.100 € (-5,61 %)     LIGHTON 6.240 € (-0,95 %)     AIR LIQUIDE 176.500 € (+1,86 %)     CVC CAPITAL 12.750 € (+0,31 %)     SCHNEIDER ELECTRIC 279.975 € (-1,90 %)     SANOFI 73.960 € (-1,49 %)     EUTELSAT COMMUNIC. 2.538 € (+5,18 %)     TOTALENERGIES 67.230 € (-1,18 %)     AIRBUS 199.080 € (+2,33 %)     BNP PARIBAS ACT.A 101.060 € (-1,06 %)     J.MARTINS,SGPS 16.770 € (+0,06 %)     KERING 243.400 € (-1,58 %)     74SOFTWARE 36.500 € (+2,53 %)     COFACE 15.040 € (-0,13 %)     STMICROELECTRONICS 65.350 € (+1,33 %)     TELEPERFORMANCE 48.120 € (+4,65 %)     BIOMERIEUX 69.600 € (+1,31 %)     MICHELIN 33.920 € (+0,50 %)     FERMENTALG 0.510 € (+3,24 %)     CAPGEMINI 86.960 € (-1,14 %)     ENGIE 27.210 € (-1,38 %)     THALES 231.500 € (+2,98 %)     HEINEKEN 73.900 € (+0,41 %)     2CRSI 35.580 € (+15,97 %)     UBISOFT ENTERTAIN 5.312 € (-1,19 %)     LVMH 474.600 € (-1,96 %)     PERNOD RICARD 62.320 € (-2,41 %)     PHARMING GROUP 1.220 € (+1,50 %)     MEXEDIA 4.190 € (-6,47 %)     IPSEN 168.800 € (0,00 %)     PUBLICIS GROUPE SA 81.620 € (-5,60 %)     PROSUS 38.050 € (+0,16 %)     CARREFOUR 15.975 € (-1,69 %)     DASSAULT AVIATION 295.600 € (+2,92 %)     MAGNUM 15.266 € (+0,20 %)     EDENRED 22.390 € (-0,49 %)     ADYEN 817.000 € (-0,41 %)     CSG 13.144 € (+2,90 %)     SES 7.765 € (+8,37 %)     LNA SANTE 35.000 € (+0,86 %)     ALTEN 53.450 € (+0,85 %)     North Atlantic En. 46.600 € (+5,91 %)     GETLINK SE 18.210 € (-2,10 %)     ASML HOLDING 1 730.000 € (+0,50 %)     SAFRAN 350.100 € (+1,48 %)     GTT 186.400 € (+0,27 %)     FDJ UNITED 21.560 € (+0,79 %)     ESSILORLUXOTTICA 165.400 € (+0,82 %)     WOLTERS KLUWER 55.200 € (-2,20 %)     HERMES INTL 1 583.000 € (-0,94 %)     AEGON 7.486 € (+0,65 %)     ING GROEP N.V. 27.415 € (-0,92 %)     STELLANTIS NV 5.071 € (+1,79 %)     B.COM.PORTUGUES 1.038 € (+0,29 %)     WENDEL 82.050 € (-0,24 %)  
News Réglementées
01/07/2026 09:00

Original-Research: OHB SE (von NuWays AG): BUY

Original-Research: OHB SE - from NuWays AG

01.07.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to OHB SE

Company Name:OHB SE
ISIN:DE0005936124
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 340
Target price on sight of:12 months
Last rating change:
Analyst:Simon Keller

Funded for the next growth orbit, chg. & PT Up

Following the capital increase and the new mid-term outlook presented at its CMD, OHB is in our view well positioned to win and execute on upcoming contracts. This is supported by a strengthened balance sheet, a clear right to win as Europe’s leading independent space prime, and a multi-year demand upcycle backed by rising ESA, EU and national defence budgets. This supports our BUY.

Mid-term targets imply c. 27% organic sales CAGR into 2030e. The company targets total operating mid-term performance of € >4bn (eNuW: 2030e), up from € 1.2bn in 2025, and an adj. EBITDA margin of c. 13%, i.e. +c. 3pp vs 2025. The margin bridge rests on scale, industrialisation and a richer defence mix (eNuW: 50% vs 22% today). The defence step-up, led by SATCOMBw4, could support margins slightly above the 13% target (eNuW), as OHB was already targeting >12% before the recent increase in German defence spending and as management indicated that one large identified opportunity could support an overshoot versus the targets. HENSOLDT, which also executes large, long-cycle development projects for the German Bundeswehr, such as the new Eurofighter radar, targets EBITDA margins of around 19%, providing a useful defence-margin reference point.

Right to win. As the only independent German space prime, with 25 years of Bundeswehr heritage, OHB is well placed for Germany's sovereignty-led programmes: SPOCK 2 (next-gen military space surveillance) via the KIRK consortium (OHB/Helsing JV, with Kongsberg and HENSOLDT); SATCOMBw4 (sovereign milsatcom worth up to € 10bn) via the OHB Rheinmetall Space Networks JV; and SBMD (space-based missile defence/early-warning worth c. € 3bn, eNuW).

OHB’s capital increase strengthens the balance sheet for industrialisation, capacity expansion and selective M&A, with c. € 482m gross proceeds already secured (up to c. € 511m possible after the smaller rights offering for existing minority shareholders). The implied share-count increase of up to c. 8.9% is seen to materially improve liquidity and index eligibility, with free float rising from c. 5.7% to slightly above 20%, helped by KKR’s parallel placement of existing shares. The Fuchs family remains majority shareholder with >60%, while KKR retains c. 20%. Transaction costs are expected to burden 2026e EBIT by c. € 5m.

Potential catalyst: Rocket Factory Augsburg (RFA). RFA remains outside OHB’s new mid-term guidance and is only captured in our valuation as a financial asset worth € 145m. Yet, the asset could become more visible soon. RFA is developing RFA ONE, a three-stage small-launch vehicle for flexible European access to orbit. Its maiden flight from SaxaVord, targeted for summer 2026, could bring it closer to commercialisation. Isar Aerospace, RFA’s closest German peer, is slightly further advanced, having already completed a first test flight with its own launcher, but it is also still pre commercial. Hence, its reported valuation of € >2bn in June 2026 (following a private financing round) provides a useful, albeit imperfect, cross-read for a potential post-first-flight valuation of RFA.

Action: the recent capital increase as well as credible new mid-term targets are reflected in our estimates (new 2030 sales: € 4bn, previously: € 3.5bn). BUY, new PT € 340 (old: € 320), on DCF.

You can download the research here: ohb-se-2026-07-01-update-en-b8460
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2357412  01.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière